Recent Posts
Medical Malpractice Reform and Employer-Sponsored Health Insurance
Using a variety of empirical specifications, there was no statistically significant evidence that noneconomic damage caps exerted any meaningful influence on the cost of employer-sponsored health insurance. The findings suggest…
Medicare Part D’s Effects on Elderly Patients’ Drug Costs & Utilization
Elderly patients’ utilization in the first year of Part D increased compared with that of near-elderly patients by 8.1% for days’ supply and 4.8% for the number of individuals filling…
How Similar Are States’ Medicaid Preferred Drug Lists?
For 42 (38%) of the drugs, there was wide consistency in PDL design, with at least 9 states classifying the drug with the same PDL status. For the other 62%…
Consumer Response To A National Marketplace For Individual Health Insurance
The objective of this analysis is to simulate the difference between national and state-specific individual insurance markets on take-up of individual health insurance. First, we reviewed the literature to characterize…
Hospital-Physician Gainsharing In Cardiology
The average in-lab cost per coronary stent patient increased from $3,338 in the fourth quarter of 2001 to $4,644 in the fourth quarter of 2006, and spending on devices and…